Stay Sharp for Updated mRNA COVID-19 Vaccines
October 2023
It’ll be all hands on deck for 2023-2024 COVID-19 vaccines.
Both mRNA vaccines (Moderna, Pfizer-BioNTech) are now monovalent...covering the Omicron XBB.1.5 SARS-CoV-2 subvariant.
Health Canada is also reviewing Novavax’s COVID-19 monovalent vaccine for 12 years and up...also targeting the XBB.1.5 subvariant.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote